Furthermore, CDCA6 depletion induced PCa cell death and proliferation arrest by regulating the expression of a key subset of genes, indicating that CDCA6 may potentially be used as a drug target in CRPC. This evidence concerns the gene CBX2 and posterior cortical atrophy.